Pattern Computer uses its proprietary Pattern Discovery Engine™ (PDE) to solve the most important, intractable problems in business and medicine. Its proprietary mathematical techniques can discover complex patterns in very-high-order data that have eluded detection by much larger systems. Pattern's “Third Wave” PDE is the core of their Project StarBright™ Drug Discovery Program, to date creating new combination treatments for TNBC (2) and HGSOC (5), all now finishing in vivo testing; as well as creating much-improved diagnostics (from 63.7% to 70-99%) in a major global colorectal cancer data set. Pattern plans to file 14 new patents on combo drugs for mCRPC, testing begins in 2024. The PDE is also behind their ProSpectral™ diagnostics research instrument, able to detect COVID in 3 seconds at 98.8% balanced accuracy, using hyperspectral light and two drops of saliva. Now testing at various global labs for multiple diseases and cancer, and at two national labs for bioweapons research.